Earnings call transcript: Blueprint Medicines Q4 2024 misses EPS estimates
Blueprint Medicines Corp (NASDAQ:BPMC) reported a challenging fourth quarter for 2024, missing analyst expectations for both earnings per share (EPS) and revenue. The company posted an EPS of -0.79, ...
autoevolution6d
2025 Lexus LX 700h Full-Size Luxury Hybrid SUV: How Does It Compare to Its Main Rivals?
The Japanese automaker Toyota's luxury division has announced local US pricing for the 2025 Lexus LX and its new LX 700h ...